Source: Alpha Cognition.
  • The U.S. Food and Drug Administration has accepted Alpha Cognition’s (CSE:ACOG) New Drug Application for ALPHA-1062
  • The FDA has completed its filing review on the company’s proprietary, patented, delayed release oral tablet formulation in development for the treatment of mild-to-moderate Alzheimer’s disease
  • Adverse events documented across all studies for ALPHA-1062 were less than 2 per cent and no insomnia was observed
  • Alpha Cognition Inc. last traded at $0.38 per share

The U.S. Food and Drug Administration (FDA) has accepted Alpha Cognition’s (CSE:ACOG) New Drug Application (NDA) for ALPHA-1062.

The FDA has completed its filing review on the company’s proprietary, patented, delayed release oral tablet formulation in development for the treatment of mild-to-moderate Alzheimer’s disease.

The NDA has been granted a Prescription Drug User Fee Act goal date of July 27, 2024.

Based on results from four studies conducted by the company, bioequivalence (the biochemical similarity of two or more drugs) was demonstrated for ALPHA-1062 to galantamine and galantamine ER. Adverse events documented across all studies for ALPHA-1062 were less than 2 per cent and no insomnia was observed.

“The FDA’s acceptance of our NDA for ALPHA-1062 brings us another significant step closer to delivering a much-needed treatment to patients suffering from Alzheimer’s disease,” Michael McFadden, chief executive officer of Alpha Cognition said in a news release. “We look forward to continuing our collaboration with the FDA throughout the review process.”

Alpha Cognition is a clinical-stage biopharmaceutical company developing treatments for underserved neurodegenerative diseases.

Alpha Cognition Inc. last traded at $0.38 per share.

Join the discussion: Find out what everybody’s saying about this stock on the Alpha Cognition Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online

Search suspended for SSR miners missing after Türkiye mine collapse

SSR Mining (TSX:SSRM) provided an update on the tragedy that struck its Çöpler gold operation in eastern Türkiye.
stock market down

@ the Bell: Bumpy start to a holiday-shortened week

Early data that showed domestic inflation cooled more than expected couldn't give enough lift for Canada’s main stock index on Tuesday.

SweetWater Brewing inks partnership with Atlanta United FC

SweetWater Brewing, a subsidiary of Tilray Brands, has signed on as official craft beer partner of Major League Soccer’s Atlanta United FC.